4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-049398
President and CEO gave up 23,872 shares (to pay taxes)
- President and CEO acquired 83,092 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-09-01 | Option exercise | +83,092 | 1,170,023 | D: show line 1 in the form | ||
| Walker Neal President and CEO | 2020-09-01 | Shares withheld for taxes | −23,872 | $2.33 | $55,622 | 1,146,151 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2020-09-01 | Grant or award · Restricted stock units | +83,092 | 83,092 | D: show line 3 in the form | |||||
| Walker Neal President and CEO | 2020-09-01 | Option exercise · Restricted stock units | −83,092 | 0 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…